MTOR and idiopathic pulmonary fibrosis: Although ATP-competitive mTOR inhibitor was shown to be highly effective in blocking collagen synthesis in live precision-cut IPF lung tissue slices, the long-term tolerability of dual mTORC1 and mTORC2 inhibition remains unknown.